Stock listing

A0Q2S4 Stock Price, News, Filings & Events — Codexis, Inc.

Selected listing: A0Q2S4 · LSX · EUR · DE

This page tracks Codexis, Inc.'s A0Q2S4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0Q2S4:LSX. A0Q2S4:LSX is the stock-level entry point for investors researching Codexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Codexis, Inc. (ticker: CDXS) is a public company based in the United States with a market capitalization of approximately $134.5 million. The company focuses on developing and commercializing innovative enzyme-based solutions for various industries. Codexis aims to enhance product performance and sustainability through its advanced biotechnology platform.

A0Q2S4:LSXEURDEUpdated August 28, 2026
Codexis, Inc. logo
Ticker
A0Q2S4:LSX
Asset type
Stock
Market cap
$174.1M
Sector
Process Industries
Industry
Chemicals: Specialty
Exchange
LSX
Currency
EUR

Codexis, Inc. A0Q2S4:LSX stock context

This page tracks Codexis, Inc.'s A0Q2S4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0Q2S4:LSX. A0Q2S4:LSX is the stock-level entry point for investors researching Codexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Codexis, Inc. (ticker: CDXS) is a public company based in the United States with a market capitalization of approximately $134.5 million. The company focuses on developing and commercializing innovative enzyme-based solutions for various industries. Codexis aims to enhance product performance and sustainability through its advanced biotechnology platform.

Latest news from Codexis, Inc.

All Codexis, Inc. news →

Codexis, Inc. earnings calls

Research Codexis, Inc.

Alternate listings